{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:38:13Z","timestamp":1789609093418,"version":"build-2803163510"},"reference-count":20,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T00:00:00Z","timestamp":1649116800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hematology Reports"],"abstract":"<jats:p>Thrombotic microangiopathies (TMA) are a rare group of life-threatening hematological conditions characterized by thrombocytopenia and microangiopathic hemolytic anemia. Although our understanding of the pathophysiology and the availability of diagnostic testing has improved for primary TMAs, such as thrombotic thrombocytopenic purpura, the pathophysiology underlying secondary TMAs, including drug-induced TMAs (DITMAs), remains less clear. In this case report, we present the unique case of a patient with a history of multiple myeloma that presented four months after the initiation of bortezomib therapy with a bortezomib-associated TMA that responded to therapeutic plasma exchange (TPE) with plasma replacement and eculizumab therapy. This case demonstrates the possible utility of TPE with plasma replacement and eculizumab therapy in DITMA patients that fail to respond following a trial of holding the suspected medication.<\/jats:p>","DOI":"10.3390\/hematolrep14020018","type":"journal-article","created":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T11:26:07Z","timestamp":1649157967000},"page":"119-125","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Unique Presentation of Bortezomib-Associated Thrombotic Microangiopathy Responsive to Therapeutic Plasma Exchange and Eculizumab Therapy"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8195-4970","authenticated-orcid":false,"given":"Robert C.","family":"Sterner","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI 53792, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5978-1927","authenticated-orcid":false,"given":"William Nicholas","family":"Rose","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI 53792, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,4,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"E153","DOI":"10.1503\/cmaj.160142","article-title":"Thrombotic microangiopathies: A general approach to diagnosis and management","volume":"189","author":"Arnold","year":"2017","journal-title":"CMAJ Can. Med. Assoc. J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"E348","DOI":"10.1002\/ajh.24447","article-title":"Proteasome inhibitor associated thrombotic microangiopathy","volume":"91","author":"Yui","year":"2016","journal-title":"Am. J. Hematol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJMra020528","article-title":"Thrombotic microangiopathies","volume":"347","author":"Moake","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"bcr2012006461","DOI":"10.1136\/bcr-2012-006461","article-title":"Bortezomib-induced thrombotic thrombocytopaenic purpura","volume":"2012","author":"Mehta","year":"2012","journal-title":"BMJ Case Rep."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1055\/s-2005-925474","article-title":"Drug-induced thrombotic microangiopathy","volume":"31","author":"Zakarija","year":"2005","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.3109\/10428194.2014.977887","article-title":"Thrombotic microangiopathy complicating bortezomib-based therapy for multiple myeloma","volume":"56","author":"Chan","year":"2015","journal-title":"Leuk. Lymphoma"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Salmenniemi, U., and Remes, K. (2012). Thrombotic microangiopathy associated with bortezomib treatment in a patient with relapsed multiple myeloma. Hematol. Rep., 4.","DOI":"10.4081\/hr.2012.e13"},{"key":"ref_8","first-page":"537","article-title":"Mechanism of action and determinants of sensitivity to the proteasome inhibitor bortezomib in multiple myeloma therapy","volume":"57","author":"Ri","year":"2016","journal-title":"Rinsho Ketsueki"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2147\/tcrm.2006.2.3.271","article-title":"Bortezomib (Velcadetrade mark) in the Treatment of Multiple Myeloma","volume":"2","author":"Morgan","year":"2006","journal-title":"Ther. Clin. Risk Manag."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s12185-008-0140-1","article-title":"Thrombotic microangiopathy after treatment with bortezomib and dexamethasone in a patient with multiple myeloma","volume":"88","author":"Morita","year":"2008","journal-title":"Int. J. Hematol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1445-5994.2011.02458.x","article-title":"Multiple myeloma presenting with a fever of unknown origin and development of thrombotic thrombocytopenic purpura post-bortezomib","volume":"41","author":"Moore","year":"2011","journal-title":"Intern. Med. J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1056\/NEJMra1312353","article-title":"Syndromes of thrombotic microangiopathy","volume":"371","author":"George","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1111\/trf.15954","article-title":"Diagnostic accuracy of the PLASMIC score in patients with suspected thrombotic thrombocytopenic purpura: A systematic review and meta-analysis","volume":"60","author":"Paydary","year":"2020","journal-title":"Transfusion"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1016\/S2352-3026(17)30026-1","article-title":"Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: A cohort study","volume":"4","author":"Bendapudi","year":"2017","journal-title":"Lancet Haematol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1053\/ajkd.1998.v32.pm9708619","article-title":"Successful treatment of cisplatin-induced hemolytic uremic syndrome with therapeutic plasma exchange","volume":"32","author":"Palmisano","year":"1998","journal-title":"Am. J. Kidney Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1537-2995.2004.00700.x","article-title":"Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: A diagnostic dilemma","volume":"44","author":"George","year":"2004","journal-title":"Transfusion"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1053\/ajkd.2000.17690","article-title":"Cyclosporine and tacrolimus-associated thrombotic microangiopathy","volume":"36","author":"Pham","year":"2000","journal-title":"Am. J. Kidney Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1161\/01.STR.0000109253.66918.5E","article-title":"Clopidogrel-associated TTP: An update of pharmacovigilance efforts conducted by independent researchers, pharmaceutical suppliers, and the Food and Drug Administration","volume":"35","author":"Zakarija","year":"2004","journal-title":"Stroke"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"143426","DOI":"10.1155\/2014\/143426","article-title":"Anti-VEGF Cancer Therapy in Nephrology Practice","volume":"2014","author":"Izzedine","year":"2014","journal-title":"Int. J. Nephrol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/ajh.2830470407","article-title":"Quinine-induced immune thrombocytopenia with hemolytic uremic syndrome: Clinical and serological findings in nine patients and review of literature","volume":"47","author":"Gottschall","year":"1994","journal-title":"Am. J. Hematol."}],"container-title":["Hematology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2038-8330\/14\/2\/18\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:48:45Z","timestamp":1760136525000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2038-8330\/14\/2\/18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,5]]},"references-count":20,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,6]]}},"alternative-id":["hematolrep14020018"],"URL":"https:\/\/doi.org\/10.3390\/hematolrep14020018","relation":{},"ISSN":["2038-8330"],"issn-type":[{"value":"2038-8330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,5]]}}}